Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis

被引:41
|
作者
Xu, Xin [1 ,2 ]
Lu, Linlin [2 ,3 ]
Dong, Quanyong [1 ,2 ]
Li, Xiaolin [1 ,2 ]
Zhang, Nannan [1 ,2 ]
Xin, Yongning [1 ,2 ,3 ]
Xuan, Shiying [1 ,2 ,3 ]
机构
[1] Dalian Med Univ, Qingdao Municipal Hosp, Dept Gastroenterol, Qingdao, Peoples R China
[2] Digest Dis Key Lab Qingdao, Qingdao, Peoples R China
[3] Qingdao Municipal Hosp, Cent Labs, Qingdao, Peoples R China
来源
LIPIDS IN HEALTH AND DISEASE | 2015年 / 14卷
关键词
Nonalcoholic fatty liver disease; Atherosclerosis; Insulin resistance; Metabolic syndrome; Cardiovascular disease; CORONARY-ARTERY-DISEASE; OBSTRUCTIVE SLEEP-APNEA; INTIMA-MEDIA THICKNESS; NF-KAPPA-B; TYPE-2; DIABETIC-PATIENTS; EPICARDIAL ADIPOSE-TISSUE; CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; CAROTID ATHEROSCLEROSIS;
D O I
10.1186/s12944-015-0141-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is a metabolic stress-induced liver disease that is closely related not only to genetic susceptibility but also to insulin resistance and highly linked with metabolic syndrome. In recent years, the prevalence of NAFLD has increased rapidly, paralleling the epidemic of type 2 diabetes mellitus and obesity leading to cardiovascular disease. It has been demonstrated that NAFLD is highly associated with atherosclerosis. With recently gained knowledge, it appears that NAFLD may induce insulin resistance, dyslipidemia, oxidative stress, inflammation, and fluctuation of adipokines associated with atherosclerosis. In this review, we aimed to summarize recent discoveries related to both NAFLD and atherosclerosis, and to identify possible mechanisms linking them.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Nonalcoholic fatty liver disease: Evolving paradigms
    Lonardo, Amedeo
    Nascimbeni, Fabio
    Maurantonio, Mauro
    Marrazzo, Alessandra
    Rinaldi, Luca
    Adinolfi, Luigi Elio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (36) : 6571 - 6592
  • [42] Insulin Resistance in Nonalcoholic Fatty Liver Disease
    Bugianesi, E.
    Moscatiello, S.
    Ciaravella, M. F.
    Marchesini, G.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (17) : 1941 - 1951
  • [43] Epigenetics factors in nonalcoholic fatty liver disease
    Pirola, Carlos Jose
    Sookoian, Silvia
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (06) : 521 - 536
  • [44] Relationship of the Degree of Sarcopenia with the Severity of Nonalcoholic Fatty Liver Disease and Cardiometabolic Risk in Adolescents
    Kwon, Yoowon
    Chung, Jin A.
    Choi, You Jin
    Lee, Yoo Min
    Choi, So Yoon
    Yoo, In Hyuk
    Kim, Tae Hyeong
    Jeong, Su Jin
    LIFE-BASEL, 2024, 14 (11):
  • [45] Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults
    Nam, Ji Sun
    Jo, Sehee
    Kang, Shinae
    Ahn, Chul Woo
    Kim, Kyung Rae
    Park, Jong Suk
    CLINICA CHIMICA ACTA, 2016, 461 : 14 - 18
  • [46] Advances in Pediatric Nonalcoholic Fatty Liver Disease
    Loomba, Rohit
    Sirlin, Claude B.
    Schwimmer, Jeffrey B.
    Lavine, Joel E.
    HEPATOLOGY, 2009, 50 (04) : 1282 - 1293
  • [47] Association between nonalcoholic fatty liver disease and coronary artery disease
    Vilar, Consuelo P.
    Cotrim, Helma P.
    Florentino, Gesira S.
    Barreto, Cibelle P. V.
    Florentino, Andre Vinicius A.
    Bragagnoli, Gerson
    Schwingel, Paulo A.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2013, 59 (03): : 290 - 297
  • [48] Recent advances in nonalcoholic fatty liver disease
    Cheung, Onpan
    Sanyal, Arun J.
    CURRENT OPINION IN GASTROENTEROLOGY, 2009, 25 (03) : 230 - 237
  • [49] Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study
    Kim, Byung Jin
    Cheong, Eun Sun
    Kang, Jung Gyu
    Kim, Bum Soo
    Kang, Jin Ho
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (03) : 619 - 626
  • [50] Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
    Lonardo, Amedeo
    Sookoian, Silvia
    Chonchol, Michel
    Loria, Paola
    Targher, Giovanni
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (29) : 5177 - 5192